ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0L35 Sarepta Therapeutics Inc

90.83
0.00 (0.00%)
20 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.31B1.64B1.82B2.98B3.15B3.13B3.26B3.96B
Total Current Assets 1.23B1.43B1.47B2.49B2.6B2.56B2.58B3.07B
Cash and Equivalents 599.69M370.83M835.08M1.5B2.12B966.78M428.43M1.1B
Total Non-Current Assets 789.22M1.03B818.19M761.76M928.01M384.95M859.34M1.53B
Total Liabilities 518.75M609.8M1B2.22B2.22B2.74B2.41B2.44B
Total Current Liabilities 88.33M173.69M264.77M416.03M452.73M619.6M653.66M731.68M
Total Non-Current Liabilities 855.29M856.66M1.42B2.8B2.86B3.67B2.88B2.84B
Total Equity 789.22M1.03B818.19M761.76M928.01M384.95M859.34M1.53B
Common Equity 6k7k8k8k9k9k9k10k
Retained Earnings -1.22B-1.58B-2.29B-2.85B-3.21B-3.91B-4.45B-4.21B